Oct 19, 2016, 09:18 AM by Michael Croft

The Boston Globe | The gene-editing technology company with Cambridge operations sold 4 million share at $14 each. It had planned to sell 4.7 million shares at $15 to $17 apiece.

Oct 19, 2016, 08:24 AM by Michael Croft

PRINCETON, NJ - Oct 19, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that the Office of Generic Drugs (OGD), US Food and Drug Administration (FDA) has awarded it a multi-year research grant to create and validate a physiologically-based pharmacokinetic (PBPK) modeling and simulation framework that complements existing models within the Simcyp® Population-based Simulator

Oct 19, 2016, 06:59 AM by Michael Croft

OXFORDSHIRE, UK - Oct 19, 2016 - Oxford Genetics Ltd, a leading biotech which specialises in DNA design, protein expression optimization and cell line development technologies and services, has moved its operations to new state-of-the-art laboratories at The Oxford Science Park

Oct 19, 2016, 03:17 AM by Michael Croft

BASEL, SWITZERLAND - Oct 19, 2016 - BC Platforms, a world leader in genomic data management solutions, today announced that the Center for Molecular Medicine (CMM) at the Karolinska Institute has extended its research partnership with BC Platforms to encompass its newest version of the platform and include its BC|GENOME and BC|TILING tools to add capacity for large scale next generation sequencing as well as superior data handling and analytics

Oct 19, 2016, 02:17 AM by Michael Croft

SHIRLEY, NY - Oct 19, 2016 - Creative BioMart, a world leading biotech company committed to providing advanced tools for life sciences studies, is pleased to updated its official website recently

Oct 18, 2016, 16:55 PM by Michael Croft

Bio-IT World | This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine built on GA4GH APIs.

Oct 18, 2016, 11:04 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC, UNITED STATES - Oct 18, 2016 - Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at IRT 2016 — Interactive Response Technologies in Clinical Trials, October 25-26, 2016 in Philadelphia

Oct 18, 2016, 10:50 AM by Michael Croft

Xconomy | Veritas Genetics, which sells genome sequencing and genetic screening tests, has received a $30 million Series B round of funding to add more products, build out its digital tools for consumers, and ink partnerships with hospitals and researchers around the world.

Oct 18, 2016, 10:12 AM by Michael Croft

Microsoft Blog | In a blog post this morning, Microsoft announced that it has come up with a way to "significantly reduce the time it takes to do the major computational aspects of sequencing a genome." Microsoft is running the BWA aligner and GATK on the Azure cloud, and says it is 7x faster than previously.

Oct 18, 2016, 09:56 AM by Michael Croft

BIRMINGHAM, UK - Oct 19, 2016 - Designed specifically with researchers in mind, the Birmingham Environment for Academic Research (BEAR) Cloud will augment an already rich set of IT services at the University of Birmingham and will be used by academics across all disciplines, from Medicine to Archaeology, and Physics to Theology

Oct 18, 2016, 06:24 AM by Michael Croft

CAMBRIDGE, UK - Oct 18, 2016 - “At Congenica we realise that there is huge value in being able to share data to see how others have interpreted the same gene variant,” says Dr Matthew Hurles, co-founder of Congenica, a world leader in genomic analysis and interpretation

Oct 17, 2016, 10:28 AM by Michael Croft

WIRED | Recent high-profile donations and initiatives highlight the private control of publicly funded biomedical research. The injection of private money into science is creating power alliances and disrupting the longstanding public research-funding model.

Oct 17, 2016, 10:08 AM by Michael Croft

The Motley Fool | On Oct. 10, Exelixis announced results from its phase 2 CABOSUN study of Cabometyx in patients with previously untreated advanced kidney cancer. This clinical trial was structured as a head-to-head comparison between Cabometyx and Pfizer's Sutent, and Cabometyx emerged as the clear winner.

Oct 17, 2016, 09:00 AM by Michael Croft

NOTTINGHAM, NOTTINGHAM - Oct 17, 2016 - Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc

Oct 17, 2016, 08:47 AM by Michael Croft

UPPSALA, SWEDEN - Oct 17, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced a 5 million SEK investment into a new GLP (Good Laboratory Practice) compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response to growing customer demand

Oct 14, 2016, 12:20 PM by Michael Croft

Bio-IT World | The Global Alliance for Genomics in Health (GA4GH) has selected Ewan Birney, Director of the European Bioinformatics Institute (EMBL-EBI), to steward its member organizations in producing solutions for sharing genomic and clinical data. Birney took to his blog to address the new position.

Oct 14, 2016, 09:35 AM by Michael Croft

Optibrium Introduces Database Query Interface for StarDrop Providing instant access to compound data to interpret, model and guide drug discovery decisions CAMBRIDGE, UK, 13 October 2016 – Optibrium™, a developer of software for small molecule drug

Oct 13, 2016, 11:30 AM by Michael Croft

Bio-IT World | Genetics research is not as diverse as one would hope. Present discussions on this issue have led to the launching of multiple initiatives, including those from Illumina and 23andMe this week, whose goal is to develop the data pool in Africa.

Oct 13, 2016, 10:01 AM by Michael Croft

Computerworld | The idea with IBM's new Cloud Object Storage service: If dispersing data among storage nodes can make it more secure and less prone to loss, spreading it across far-flung cloud data centers make it even more so.

Oct 13, 2016, 08:15 AM by Michael Croft

PRINCETON, NJ - Oct 13, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Peking Union Medical College (PUMC) Hospital in Beijing, China, and Keio University in Tokyo, Japan have become Phoenix® Centers of Excellence